• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

SK Capital Announces Agreement to Acquire Fire Safety and Oil Additives Businesses from Israel Chemicals Ltd.

SK Capital Partners

SK Capital Partners / December 14, 2017

New York, December 8, 2017 – SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced …

[Read more...] about SK Capital Announces Agreement to Acquire Fire Safety and Oil Additives Businesses from Israel Chemicals Ltd.

SK Capital Partners / November 30, 2017

Tel Aviv, Israel, November 28, 2017 – Wavelength Pharmaceuticals Ltd. (“Wavelength” or the “Company”), a former subsidiary of Perrigo Company plc that was …

[Read more...] about Wavelength Pharmaceuticals Names Iftach Seri as Chief Executive Officer and Tami Cohen as Chief Financial Officer

SK Capital Partners / November 21, 2017

New York, NY and Tel Aviv, Israel, November 21, 2017 – SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals …

[Read more...] about SK Capital Closes Acquisition of Perrigo’s API Business and Changes Name to Wavelength Pharmaceuticals

SK Capital Partners / October 3, 2017

NEW YORK, October 3, 2017 – SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceutical …

[Read more...] about SK Capital Expands Team with Two New Professionals

SK Capital Partners / August 17, 2017

New Investment Aimed to Support the Company’s Growth and Potential Industry Consolidation NEW YORK and BASEL, SWITZERLAND, August 17, 2017 – SK Capital …

[Read more...] about SK CAPITAL CONTINUES TO INVEST IN ARCHROMA

SK Capital Partners / August 11, 2017

New York, August 10, 2017 – SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, announced that it …

[Read more...] about SK Capital Announces Agreement to Acquire Perrigo Company plc’s Active Pharmaceutical Ingredients Business

  • ➞
  • Go to page 1
  • Interim pages omitted …
  • Go to page 12
  • Go to page 13
  • Go to page 14
  • Go to page 15
  • ➞

Primary Sidebar

To request for a copy of our ESG report, please click here.

© 2022 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login